Vical Inc (VICL.OQ)
Get access to over 18 million research reports from over 1,700 sources.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
- private equity
- third-party document and information retrieval
- and much, much more…
|80||1999||Independent Chairman of the Board|
|63||2014||President, Chief Executive Officer, Director|
|50||2017||Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer|
|51||2012||Vice President - Clinical Vaccines|
|54||2006||Vice President - Vaccine Research|
- BRIEF-Vical Reports Q4 Loss Per Share Of $0.21
- BRIEF-Vical Announces Restructuring To Focus Resources On Hsv-2 And Antifungal Clinical Programs
- BUZZ-Vical: Falls as herpes vaccine fails late-stage trial
- BRIEF-Astellas Says Cytomegalovirus Vaccine (ASP0113) Did Not Meet Its Primary Or Secondary Endpoints In Phase 3 Helios Clinical Trial
- BRIEF-Stonepine Capital Management reports 6.6 pct passive stake in Vical